vs
Side-by-side financial comparison of AVIAT NETWORKS, INC. (AVNW) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $111.5M, roughly 1.5× AVIAT NETWORKS, INC.). AVIAT NETWORKS, INC. runs the higher net margin — 5.1% vs -82.0%, a 87.1% gap on every dollar of revenue. On growth, AVIAT NETWORKS, INC. posted the faster year-over-year revenue change (-5.7% vs -22.7%). AVIAT NETWORKS, INC. produced more free cash flow last quarter ($22.5M vs $-36.6M). Over the past eight quarters, AVIAT NETWORKS, INC.'s revenue compounded faster (0.3% CAGR vs -11.5%).
Aviat Networks, Inc. is a global provider of microwave transport and backhaul solutions, providing public and private operators with communications infrastructure to serve telecommunications operators and enterprise customers.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
AVNW vs PTCT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $111.5M | $164.7M |
| Net Profit | $5.7M | $-135.0M |
| Gross Margin | 32.4% | — |
| Operating Margin | 6.5% | -43.3% |
| Net Margin | 5.1% | -82.0% |
| Revenue YoY | -5.7% | -22.7% |
| Net Profit YoY | 27.2% | -104.8% |
| EPS (diluted) | $0.44 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $111.5M | $164.7M | ||
| Q3 25 | $107.3M | $211.0M | ||
| Q2 25 | $115.3M | $178.9M | ||
| Q1 25 | $112.6M | $1.2B | ||
| Q4 24 | $118.2M | $213.2M | ||
| Q3 24 | $88.4M | $196.8M | ||
| Q2 24 | $116.7M | $186.7M | ||
| Q1 24 | $110.8M | $210.1M |
| Q4 25 | $5.7M | $-135.0M | ||
| Q3 25 | $162.0K | $15.9M | ||
| Q2 25 | $5.2M | $-64.8M | ||
| Q1 25 | $3.5M | $866.6M | ||
| Q4 24 | $4.5M | $-65.9M | ||
| Q3 24 | $-11.9M | $-106.7M | ||
| Q2 24 | $1.5M | $-99.2M | ||
| Q1 24 | $3.9M | $-91.6M |
| Q4 25 | 32.4% | — | ||
| Q3 25 | 33.2% | — | ||
| Q2 25 | 34.2% | — | ||
| Q1 25 | 34.9% | — | ||
| Q4 24 | 34.6% | — | ||
| Q3 24 | 22.4% | — | ||
| Q2 24 | 35.3% | — | ||
| Q1 24 | 32.5% | — |
| Q4 25 | 6.5% | -43.3% | ||
| Q3 25 | 4.8% | 1.4% | ||
| Q2 25 | 7.7% | -19.5% | ||
| Q1 25 | 8.3% | 82.5% | ||
| Q4 24 | 6.7% | -76.2% | ||
| Q3 24 | -17.6% | -27.7% | ||
| Q2 24 | 4.7% | -21.5% | ||
| Q1 24 | 5.1% | -21.6% |
| Q4 25 | 5.1% | -82.0% | ||
| Q3 25 | 0.2% | 7.5% | ||
| Q2 25 | 4.5% | -36.3% | ||
| Q1 25 | 3.1% | 73.7% | ||
| Q4 24 | 3.8% | -30.9% | ||
| Q3 24 | -13.4% | -54.2% | ||
| Q2 24 | 1.3% | -53.1% | ||
| Q1 24 | 3.5% | -43.6% |
| Q4 25 | $0.44 | $-1.63 | ||
| Q3 25 | $0.01 | $0.20 | ||
| Q2 25 | $0.42 | $-0.83 | ||
| Q1 25 | $0.27 | $10.04 | ||
| Q4 24 | $0.35 | $-0.85 | ||
| Q3 24 | $-0.94 | $-1.39 | ||
| Q2 24 | $0.11 | $-1.29 | ||
| Q1 24 | $0.30 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.5M | $1.9B |
| Total DebtLower is stronger | $105.4M | — |
| Stockholders' EquityBook value | $271.6M | $-205.3M |
| Total Assets | $659.4M | $2.9B |
| Debt / EquityLower = less leverage | 0.39× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $86.5M | $1.9B | ||
| Q3 25 | $64.8M | $1.7B | ||
| Q2 25 | $59.7M | $2.0B | ||
| Q1 25 | $49.4M | $2.0B | ||
| Q4 24 | $52.6M | $1.1B | ||
| Q3 24 | $51.0M | $1.0B | ||
| Q2 24 | $64.6M | $1.1B | ||
| Q1 24 | $59.2M | $884.8M |
| Q4 25 | $105.4M | — | ||
| Q3 25 | $106.5M | — | ||
| Q2 25 | $87.6M | — | ||
| Q1 25 | $73.9M | — | ||
| Q4 24 | $74.9M | — | ||
| Q3 24 | $83.4M | — | ||
| Q2 24 | $48.4M | — | ||
| Q1 24 | $48.9M | — |
| Q4 25 | $271.6M | $-205.3M | ||
| Q3 25 | $263.6M | $-155.8M | ||
| Q2 25 | $263.2M | $-206.5M | ||
| Q1 25 | $256.1M | $-185.8M | ||
| Q4 24 | $249.6M | $-1.1B | ||
| Q3 24 | $247.1M | $-1.1B | ||
| Q2 24 | $255.9M | $-980.2M | ||
| Q1 24 | $256.0M | $-893.9M |
| Q4 25 | $659.4M | $2.9B | ||
| Q3 25 | $643.3M | $2.6B | ||
| Q2 25 | $633.3M | $2.6B | ||
| Q1 25 | $628.3M | $2.7B | ||
| Q4 24 | $594.1M | $1.7B | ||
| Q3 24 | $590.9M | $1.8B | ||
| Q2 24 | $535.2M | $1.9B | ||
| Q1 24 | $490.3M | $1.8B |
| Q4 25 | 0.39× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $23.9M | $-34.3M |
| Free Cash FlowOCF − Capex | $22.5M | $-36.6M |
| FCF MarginFCF / Revenue | 20.2% | -22.3% |
| Capex IntensityCapex / Revenue | 1.3% | 1.4% |
| Cash ConversionOCF / Net Profit | 4.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.1M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.9M | $-34.3M | ||
| Q3 25 | $-11.7M | $-66.3M | ||
| Q2 25 | $10.5M | $-58.3M | ||
| Q1 25 | $1.6M | $870.1M | ||
| Q4 24 | $20.8M | $-30.0M | ||
| Q3 24 | $-27.2M | $-77.0M | ||
| Q2 24 | $8.3M | $-71.5M | ||
| Q1 24 | $15.3M | $70.8M |
| Q4 25 | $22.5M | $-36.6M | ||
| Q3 25 | $-13.5M | $-69.7M | ||
| Q2 25 | $8.2M | $-59.6M | ||
| Q1 25 | $-1.2M | $868.4M | ||
| Q4 24 | $18.3M | $-33.8M | ||
| Q3 24 | $-32.6M | $-77.5M | ||
| Q2 24 | $7.5M | $-78.8M | ||
| Q1 24 | $14.8M | $61.2M |
| Q4 25 | 20.2% | -22.3% | ||
| Q3 25 | -12.6% | -33.1% | ||
| Q2 25 | 7.1% | -33.3% | ||
| Q1 25 | -1.0% | 73.8% | ||
| Q4 24 | 15.5% | -15.8% | ||
| Q3 24 | -36.8% | -39.4% | ||
| Q2 24 | 6.4% | -42.2% | ||
| Q1 24 | 13.4% | 29.1% |
| Q4 25 | 1.3% | 1.4% | ||
| Q3 25 | 1.6% | 1.6% | ||
| Q2 25 | 2.0% | 0.7% | ||
| Q1 25 | 2.5% | 0.1% | ||
| Q4 24 | 2.1% | 1.8% | ||
| Q3 24 | 6.1% | 0.3% | ||
| Q2 24 | 0.7% | 4.0% | ||
| Q1 24 | 0.4% | 4.6% |
| Q4 25 | 4.18× | — | ||
| Q3 25 | -72.48× | -4.17× | ||
| Q2 25 | 2.02× | — | ||
| Q1 25 | 0.46× | 1.00× | ||
| Q4 24 | 4.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.37× | — | ||
| Q1 24 | 3.96× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNW
| Products | $81.2M | 73% |
| Services | $30.3M | 27% |
PTCT
Segment breakdown not available.